BioPharma
Medicine Manufacturers from Europe Eyeing US Tariff Move
The medicine manufacturers from Europe are bracing for President Donald Trump’s plan to slap tariffs of almost 250% on medicine imported from the EU.
The declaration...
BioPharma
US Biotech Companies Need Government Aid to Match with...
The lawmakers in Washington have shared the angst of US drugmakers, which have been surpassed by the fast-progressing biotechnology sector of China, but have not...
News
Your Guide for Turning Grief into Action
Grief is a deeply personal and often overwhelming experience. When we lose someone we love, the pain can feel insurmountable. But amid sorrow, many people...
News
Why Use a Provider Network for Pain Management After...
Pain after an accident can be overwhelming and can affect every part of life. Injuries can make moving, resting, and handling everyday tasks hard. Getting...
News
How Early Regulatory Planning Saves Time and Money in...
Incorporating early regulatory planning in product development can significantly reduce costs and enhance efficiency. Collaborating with regulatory experts ensures thorough evaluations and strategic planning, optimizing...
BioPharma
America’s AI Action Plan Boosts Pharmaceutical Innovation
Accelerating Pharmaceutical and Biopharmaceutical Innovation through America’s AI Action Plan
America’s AI Action Plan, unveiled in July 2025, lays out a comprehensive strategy to propel the...
BioPharma
Trump To Roll-Out 340B Drugs Discount Program in 2026
The Trump administration is going to pilot a voluntary program in 2026, wherein the pharmaceutical companies can offer rebates for certain drugs to hospitals that...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.